livehealth.store

Novadoz Pharmaceuticals recalls

Novadoz Pharmaceuticals has 1 recall on record with the FDA and USDA, the earliest in 2026 and the latest reported on 4 Feb 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls1since 2026

Last 12 months1reported

Class I00% of total

Ongoing1latest 4 Feb 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 1Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why novadoz pharmaceuticals is recalled

Potency & Assay1100%

By year

20261100%

Ongoing novadoz pharmaceuticals recalls

1 active

Reported	Class	Recall	Company	Reason	Where
4 Feb 2026Drug	CLASS III	Glycopyrrolate Oral Solution, 1 mg recalled by Novadoz PharmaceuticalsGlycopyrrolate	Novadoz Pharmaceuticals	Potency & Assay	Nationwide

All novadoz pharmaceuticals recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
4 Feb 2026Drug	CLASS III	Glycopyrrolate Oral Solution, 1 mg recalled by Novadoz PharmaceuticalsGlycopyrrolate	Novadoz Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.